Literature DB >> 34289377

Maternal cecal microbiota transfer rescues early-life antibiotic-induced enhancement of type 1 diabetes in mice.

Xue-Song Zhang1, Yue Sandra Yin2, Jincheng Wang3, Thomas Battaglia4, Kimberly Krautkramer5, Wei Vivian Li6, Jackie Li4, Mark Brown7, Meifan Zhang2, Michelle H Badri8, Abigail J S Armstrong9, Christopher M Strauch10, Zeneng Wang10, Ina Nemet10, Nicole Altomare9, Joseph C Devlin4, Linchen He11, Jamie T Morton12, John Alex Chalk9, Kelly Needles9, Viviane Liao9, Julia Mount4, Huilin Li11, Kelly V Ruggles4, Richard A Bonneau13, Maria Gloria Dominguez-Bello14, Fredrik Bäckhed15, Stanley L Hazen16, Martin J Blaser17.   

Abstract

Early-life antibiotic exposure perturbs the intestinal microbiota and accelerates type 1 diabetes (T1D) development in the NOD mouse model. Here, we found that maternal cecal microbiota transfer (CMT) to NOD mice after early-life antibiotic perturbation largely rescued the induced T1D enhancement. Restoration of the intestinal microbiome was significant and persistent, remediating the antibiotic-depleted diversity, relative abundance of particular taxa, and metabolic pathways. CMT also protected against perturbed metabolites and normalized innate and adaptive immune effectors. CMT restored major patterns of ileal microRNA and histone regulation of gene expression. Further experiments suggest a gut-microbiota-regulated T1D protection mechanism centered on Reg3γ, in an innate intestinal immune network involving CD44, TLR2, and Reg3γ. This regulation affects downstream immunological tone, which may lead to protection against tissue-specific T1D injury.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NOD mice; animal models; autoimmune; cecal material transfer; gene expression; histone modification; innate immune; microRNA; microbiome; type 1 diabetes

Mesh:

Substances:

Year:  2021        PMID: 34289377      PMCID: PMC8370265          DOI: 10.1016/j.chom.2021.06.014

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   31.316


  128 in total

1.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

Review 2.  Reg3 Proteins as Gut Hormones?

Authors:  Jae Hoon Shin; Randy J Seeley
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

3.  Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice.

Authors:  Alexandra E Livanos; Thomas U Greiner; Pajau Vangay; Wimal Pathmasiri; Delisha Stewart; Susan McRitchie; Huilin Li; Jennifer Chung; Jiho Sohn; Sara Kim; Zhan Gao; Cecily Barber; Joanne Kim; Sandy Ng; Arlin B Rogers; Susan Sumner; Xue-Song Zhang; Ken Cadwell; Dan Knights; Alexander Alekseyenko; Fredrik Bäckhed; Martin J Blaser
Journal:  Nat Microbiol       Date:  2016-08-22       Impact factor: 17.745

4.  Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

Authors:  S B Wilson; S C Kent; K T Patton; T Orban; R A Jackson; M Exley; S Porcelli; D A Schatz; M A Atkinson; S P Balk; J L Strominger; D A Hafler
Journal:  Nature       Date:  1998-01-08       Impact factor: 49.962

Review 5.  Comprehensive Catalog of Currently Documented Histone Modifications.

Authors:  Yingming Zhao; Benjamin A Garcia
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-09-01       Impact factor: 10.005

6.  A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion.

Authors:  George M H Birchenough; Elisabeth E L Nyström; Malin E V Johansson; Gunnar C Hansson
Journal:  Science       Date:  2016-06-24       Impact factor: 47.728

7.  The NOD mouse: a model for insulin-dependent diabetes mellitus.

Authors:  E H Leiter
Journal:  Curr Protoc Immunol       Date:  2001-05

8.  Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces.

Authors:  B Haneberg; D Kendall; H M Amerongen; F M Apter; J P Kraehenbuhl; M R Neutra
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

9.  Identification of alternative splicing markers for breast cancer.

Authors:  Julian P Venables; Roscoe Klinck; Anne Bramard; Lyna Inkel; Geneviève Dufresne-Martin; ChuShin Koh; Julien Gervais-Bird; Elvy Lapointe; Ulrike Froehlich; Mathieu Durand; Daniel Gendron; Jean-Philippe Brosseau; Philippe Thibault; Jean-Francois Lucier; Karine Tremblay; Panagiotis Prinos; Raymund J Wellinger; Benoit Chabot; Claudine Rancourt; Sherif Abou Elela
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

Review 10.  Protease inhibition as new therapeutic strategy for GI diseases.

Authors:  Nathalie Vergnolle
Journal:  Gut       Date:  2016-04-12       Impact factor: 23.059

View more
  11 in total

Review 1.  The role of the gut microbiota in health and cardiovascular diseases.

Authors:  Lu Wang; Shiqi Wang; Qing Zhang; Chengqi He; Chenying Fu; Quan Wei
Journal:  Mol Biomed       Date:  2022-10-11

2.  Abnormal intestinal milieu in posttraumatic stress disorder is not impacted by treatment that improves symptoms.

Authors:  Robin M Voigt; Alyson K Zalta; Shohreh Raeisi; Lijuan Zhang; J Mark Brown; Christopher B Forsyth; Randy A Boley; Philip Held; Mark H Pollack; Ali Keshavarzian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-05-31       Impact factor: 4.871

3.  Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.

Authors:  Robin M Voigt; Zeneng Wang; J Mark Brown; Phillip A Engen; Ankur Naqib; Christopher G Goetz; Deborah A Hall; Leo Verhagen Metman; Maliha Shaikh; Christopher B Forsyth; Ali Keshavarzian
Journal:  Neurobiol Dis       Date:  2022-05-30       Impact factor: 7.046

Review 4.  Antibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract.

Authors:  Aline C Fenneman; Melissa Weidner; Lea Ann Chen; Max Nieuwdorp; Martin J Blaser
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-10-18       Impact factor: 73.082

Review 5.  Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.

Authors:  Raphaela I Lau; Fen Zhang; Qin Liu; Qi Su; Francis K L Chan; Siew C Ng
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-10-21       Impact factor: 73.082

Review 6.  Epigenetic regulation by gut microbiota.

Authors:  Vivienne Woo; Theresa Alenghat
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 7.  Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target.

Authors:  Tao Zhang; Guangqi Gao; Hafiz Arbab Sakandar; Lai-Yu Kwok; Zhihong Sun
Journal:  Front Nutr       Date:  2022-02-15

Review 8.  The Impact of Intestinal Microorganisms and Their Metabolites on Type 1 Diabetes Mellitus.

Authors:  Shu-Juan Zheng; Yi Luo; Jian-Hui Xiao
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-11       Impact factor: 3.249

9.  Global trends in research on miRNA-microbiome interaction from 2011 to 2021: A bibliometric analysis.

Authors:  Xiang-Yun Yan; Jun-Peng Yao; Yan-Qiu Li; Wei Zhang; Meng-Han Xi; Min Chen; Ying Li
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

10.  Variation of Serum Uric Acid Is Associated With Gut Microbiota in Patients With Diabetes Mellitus.

Authors:  Weifeng Zhang; Ting Wang; Ruixue Guo; Wen Cui; Wei Yu; Zhihui Wang; Yumin Jiang; Minghan Jiang; Xiaojie Wang; Chao Liu; Jing Xiao; Jin Shang; Xuejun Wen; Zhanzheng Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-01-18       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.